Literature DB >> 1683921

p53 germline mutations in Li-Fraumeni syndrome.

M F Santibáñez-Koref1, J M Birch, A L Hartley, P H Jones, A W Craft, T Eden, D Crowther, A M Kelsey, M Harris.   

Abstract

Germline mutations within a defined region of the p53 gene have recently been found in families with the Li-Fraumeni syndrome (LFS). In the present study this region of p53 was sequenced in affected individuals from 8 families with LFS. In only 2 of them were such mutations detected. Our findings suggest that the p53 mutation could be the primary lesion in some but not all families with LFS, and confirm that there is a "hot spot" for these mutations at the CpG dinucleotide moiety of codon 248. Assigning risks and counselling families on the basis of presence of p53 mutations should be approached with caution.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1683921     DOI: 10.1016/0140-6736(91)92303-j

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  29 in total

Review 1.  Cancer risks from germline p53 mutations.

Authors:  T Frebourg; S H Friend
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

2.  An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53.

Authors:  J M Varley; G McGown; M Thorncroft; K J Tricker; M D Teare; M F Santibanez-Koref; J Martin; J M Birch; D G Evans
Journal:  J Med Genet       Date:  1995-12       Impact factor: 6.318

3.  A unique occurrence of a cerebral atypical teratoid/rhabdoid tumor in an infant and a spinal canal primitive neuroectodermal tumor in her father.

Authors:  Ewa Izycka-Swieszewska; Maria Debiec-Rychter; Bartosz Wasag; Agnieszka Wozniak; Dariusz Gasecki; Katarzyna Plata-Nazar; Jacek Bartkowiak; Jerzy Lasota; Janusz Limon
Journal:  J Neurooncol       Date:  2003-02       Impact factor: 4.130

4.  Simultaneous adrenocortical carcinoma and ganglioneuroblastoma in a child with Turner syndrome and germline p53 mutation.

Authors:  E K Pivnick; W L Furman; G V Velagaleti; J J Jenkins; N A Chase; R C Ribeiro
Journal:  J Med Genet       Date:  1998-04       Impact factor: 6.318

5.  Heterogeneity in Li-Fraumeni families: p53 mutation analysis and immunohistochemical staining.

Authors:  C MacGeoch; G Turner; L G Bobrow; D M Barnes; D T Bishop; N K Spurr
Journal:  J Med Genet       Date:  1995-03       Impact factor: 6.318

6.  A transcribed polymorphism and sub-localisation of MDM2.

Authors:  J Heighway; E L Mitchell; D Jones; G R White; M F Santibáñez Koref
Journal:  Hum Genet       Date:  1994-05       Impact factor: 4.132

Review 7.  Familial breast cancer.

Authors:  D G Evans; I S Fentiman; K McPherson; D Asbury; B A Ponder; A Howell
Journal:  BMJ       Date:  1994-01-15

8.  Single base pair germ-line deletion in the p53 gene in a cancer predisposed family.

Authors:  R Hamelin; F Barichard; I Henry; C Junien; G Thomas
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

9.  Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma.

Authors:  L Diller; E Sexsmith; A Gottlieb; F P Li; D Malkin
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 10.  Hereditary breast cancer and family cancer syndromes.

Authors:  H T Lynch; J Lynch; T Conway; P Watson; J Feunteun; G Lenoir; S Narod; R Fitzgibbons
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.